-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Chinook Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2022.
- Chinook Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $0.000.
- Chinook Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $4.34M, a 53.2% increase year-over-year.
- Chinook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $4.34M, a 107% increase from 2021.
- Chinook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $2.09M.
- Chinook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was -$2M, a 5623% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)